Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCRN5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,264
Award facts
- Contract value 100% obligated
- $24,264.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,264 to DMS Pharmaceutical Group Inc. for EYLEA HD 8 MG/0.07 ML vials on December 11, 2025, with completion targeted for January 5, 2026. This firm fixed-price delivery order was issued without a set-aside designation, allowing the woman-owned small business pharmaceutical wholesaler to compete on an unrestricted basis. DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain and has demonstrated substantial contracting activity with DLA's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support Department of Defense healthcare operations globally. The parent IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period followed by three optional 30-month periods. Through this vehicle, DLA issues firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic medications, biologics, and medical consumables to military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FCRN5?
SPE2DR26FCRN5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FCRN5 worth?
The government has obligated $24,264 on SPE2DR26FCRN5.
Is contract SPE2DR26FCRN5 an order under another contract?
Yes. SPE2DR26FCRN5 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRN5 competed?
The extent of competition for SPE2DR26FCRN5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award